GDS Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
4,556
+1,196
+36% +$279K 0.06% 92
2026
Q1
$821K Buy
3,360
+125
+4% +$29.1K 0.05% 97
2025
Q4
$669K Sell
3,235
-84
-3% -$16.6K 0.04% 108
2025
Q3
$615K Buy
3,319
+42
+1% +$7.2K 0.04% 111
2025
Q2
$501K Sell
3,277
-94
-3% -$14.4K 0.04% 116
2025
Q1
$559K Sell
3,371
-199
-6% -$31.1K 0.05% 106
2024
Q4
$516K Sell
3,570
-462
-11% -$71.6K 0.05% 111
2024
Q3
$653K Sell
4,032
-89
-2% -$14.2K 0.06% 83
2024
Q2
$602K Sell
4,121
-42
-1% -$6.25K 0.07% 74
2024
Q1
$659K Buy
4,163
+26
+0.6% +$4.14K 0.08% 75
2023
Q4
$648K Sell
4,137
-386
-9% -$59.2K 0.09% 71
2023
Q3
$704K Sell
4,523
-80
-2% -$13.2K 0.11% 62
2023
Q2
$762K Sell
4,603
-66
-1% -$10.7K 0.12% 66
2023
Q1
$724K Sell
4,669
-316
-6% -$51K 0.13% 63
2022
Q4
$881K Sell
4,985
-447
-8% -$77.2K 0.17% 58
2022
Q3
$887K Buy
5,432
+303
+6% +$51.3K 0.2% 53
2022
Q2
$910K Buy
5,129
+93
+2% +$16.6K 0.2% 54
2022
Q1
$895K Sell
5,036
-292
-5% -$49.7K 0.2% 59
2021
Q4
$911K Buy
+5,328
New +$872K 0.2% 57

Other funds holding JNJ

GDS Wealth Management's JNJ Position: Q2 2026 in Review

GDS Wealth Management increased its Johnson & Johnson (JNJ) stake by 36% in Q2 2026, buying an estimated $279K and bringing the position to 4,556 shares worth $1.16M. The position accounts for 0.06% of the portfolio, ranked #92.

GDS Wealth Management first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • GDS Wealth Management held 4,556 shares of Johnson & Johnson worth $1.16M as of Q2 2026.
  • GDS Wealth Management bought 1,196 Johnson & Johnson shares in Q2 2026, an estimated $279K.
  • Johnson & Johnson made up 0.06% of GDS Wealth Management's portfolio in Q2 2026, its #92 holding.
  • GDS Wealth Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on GDS Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.